Linkedin Facebook Instagram X-twitter
Main Menu
PRESENTATION
SUBSCRIBE
MENU
Main Menu
PRESENTATION
SUBSCRIBE
Linkedin Facebook Instagram X-twitter

SCROLL DOWN

ALZAI Health has created the first non-invasive risk screening solution for Alzheimer’s Disease.

Proven 100% non-invasive, low-cost capability and 80% sensitivity to assess risk of being diagnosed with Alzheimer’s Disease from 1 to 10 years prior to diagnosis

  • First ever AI-driven Alzheimer’s risk-screening solution using common pre-existing health data which enables population-level screening.
  • Leverages key data available in nearly every adult medical health record worldwide, simply by applying ALZAI’s custom algorithms.
  • Proof of Concept was successfully completed. The company is now entering commercialization.
  • Strong Intellectual Property rights, as assessed by expert legal counsel.

ALZAI aims to rewrite the future of Alzheimer’s Disease.

COMPANY

MARKET

TECHNOLOGY

INVESTORS

Latest News

ALZAI Health Corp. Posted for Trading On The Frankfurt Stock Exchange

Read More

ALZAI Health Corp. Announces Marketing Services Agreement

Read More

ALZAI and Linus Health explore AI-driven collaborations aimed at early identification of Alzheimer’s disease risk and cognitive impairment

Read More

READ MORE NEWS